BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, November 28, 2024
See today's BioWorld
Home
» Other news to note for Nov. 29, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Nov. 29, 2021
Nov. 29, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adamis, Adial, Atai, Biotron, Blueprint, Bone, Clearmind, Effector, Essential, Immunomic, Immusoft, Inhibikase, Ix, Kaléo, Lengo, Link Health, Marathon, NLC, Pfizer, Philogen, Point, Pregene, Purnovate, Ranok, RDIF, Respirerx, Rosemont, Scorpion, Seelos, Sosei, Supernus, Todos, Turnstone, Valneva.
BioWorld
Briefs
Other news to note
Coronavirus